KHTRF - Knight Therapeutics Inc. (KHTRF) CEO Jonathan Ross Goodman on Q3 2020 Results - Earnings Call Transcript
Knight Therapeutics Inc. (KHTRF) Q3 2020 Earnings Conference Call November 13, 2020 08:30 AM ET Company Participants Jonathan Ross Goodman - Chief Executive Officer Samira Sakhia - President & Chief Operating Officer Amal Khouri - Vice President, Business Development Arvind Utchanah - Chief Financial Officer Conference Call Participants David Novak - Raymond James Endri Leno - National Bank Tania Gonsalves - CGF Justin Keywood - Stifel Douglas Miehm - RBC Capital Markets Presentation Operator Good morning, ladies and gentlemen. My name is James, and I will be your operator today. Welcome to the Knight Therapeutics Inc. 2020 Third Quarter Financial Results Conference Call. Before turning the call over to Jonathan Ross Goodman, CEO of Knight, listeners are reminded that portion of today's discussion may, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. The company considers
For further details see:
Knight Therapeutics Inc. (KHTRF) CEO Jonathan Ross Goodman on Q3 2020 Results - Earnings Call Transcript